Heartburn medication Zantac recalled due to possible contamination
Residents who own this over-the-counter medication may want to refrain from using it, at least for the time being.
Pharmaceutical company Sanofi announced today that it’s recalling heartburn medication Zantac as a precaution “due to potential contamination with a nitrosamine impurity called N-nitrosodimethylamine (NDMA)”.
The voluntary recall is in effect in Canada and the US.
The recall comes more than a month after Health Canada and the US Food and Drug Administration reported in September that some ranitidine medicines, including Zantac, could contain NDMA at low levels.
Manufacturers of these medicines have been asked to conduct testing to ensure the safety of the product.
Sanofi has chosen to recall the medication as evaluations continue on both the drug substance (active ingredient) and the finished drug product.
Anyone using Zantac is encouraged to contact their doctor or pharmacist with any questions.
- Peel confirms COVID-19 outbreaks at two long-term care homes in Mississauga
- BREAKING: COVID-19 outbreak declared at Credit Valley Hospital in Mississauga
- Nearly 10 per cent of restaurants have had to close permanently due to COVID-19
- LATEST: Ontario up to 3,630 confirmed COVID-19 cases, with 248 in Mississauga
- Ontario reports over 450 new COVID-19 cases, 200 cases confirmed in Mississauga
- Chicken Product Recalled Due to Potential Contamination in Mississauga
- Popular Flour Product Recalled for Contamination with Harmful Bacteria
- Bean sprouts product recalled due to possible Salmonella contamination
- Baby formula recalled due to possible contamination
- Popular Flour Being Recalled for Contamination with Harmful Bacteria